A method for detecting the presence of the gene for Huntington's disease in a subject which comprises analyzing the human chromosome 4 of the subject for a DNA polymorphism, preferably a restriction fragment length polymorphism (RFLP), linked to Huntington's Disease.

A soil disease controlling agent for preventing and controlling diseases caused by pathogenic fungi living in soil, which comprises an effective amount of at least one of a 2-cycloalkenylamine derivative and its salts as an active ingredient, and at least one inert carrier or diluent.

An eye disease inspection instrument comprising a slit light projection optical system for projecting a slit light along a projecting optical axis to a patient's eye, a first optical system for observing a crystalline lens of the patient's eye at a section which is being illuminated by the slit light, a second optical system including an objective lens having an objective optical axis substantially coaxial with respect to the projecting optical axis for performing an observation under a retroill...

An apparatus for detecting ophthalmic diseases such as a cataract in the lens of a patient's eye which includes means for focussing a laser beam at a selected spot in the lens of an eye, and according to which the light back-scattered from the eye are photoelectrically detected and converted into an electrical signal which is subsequently used to determine an autocorrelation function relating to the fluctuation of intensity of the back-scattered light over time, and to derive therefrom a protein...

A composition and method of use for the treatment of pain and inflammation associated with dental disease is disclosed. The composition comprises pine resin and salt in a 1:1-5 parts by weight relationship which is prepared by mixing the pine resin and salt, heating the mixture while stirring, cooling and grinding the resulting solid to a powder form.

A controlled release drug delivery system for placement in the periodontal pocket, gingival sulcus, tooth socket, wound or other cavity within the mouth. The system incorporates drug-containing microparticles in a fluid carrier medium, and is effective in the environment of use for up to 30 days.

An apparatus operates in an observation mode for determining a specific spot within the eye of a patient and operates in a measurement mode for measuring protein particles contained within the specific spot. The eye is illuminated with a slit light to determine a specific spot. A laser light is irradiated onto the determined specific spot. A scattered light scattered by protein particles is detected by a detector to measure the protein particles. Shutter members are actuated in the observation m...

Neutral 2:1 ligand:zinc(II) complexes in which at least one ligand is provided by a compound being 3-hydroxy-4-pyrone or a 3-hydroxy-4-pyrone in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by an aliphatic hydrocarbon group of 1 to 6 carbon atoms are of value for use in effecting an enhancement of the oxygen binding ability of a patient's haemoglobin, this being of particular application in the treatment of sickle cell disease.

A method treating virus-induced and inflammatory diseases of skin and membranes in humans or animals, comprising application of a composition consisting of one or more of the aliphatic alcohols docosanol, tetracosanol and hexacosanol in a physiologically compatible carrier is disclosed.

The method of treating Alzheimer's disease which comprises administering to a patient having the disease a safe and effective amount of a biologically active vitamin D.sub.3 or D.sub.2 material.